MOEX

EQS-News: Polyus Finance Plc: Update on Depositary for DR programs

Retrieved on: 
Thursday, February 2, 2023
London, Bank, United Kingdom, BNY Mellon, MOEX, RNS, London Stock Exchange, SEC Rule 144A, News, Growth, Regulation, Financial Conduct Authority, Republic, LSE, Gold, Security (finance)

Polyus reiterates its intention to maintain the abovementioned DR programs admitted to trading on the London Stock Exchange or other recognized stock exchanges.

Key Points: 
  • Polyus reiterates its intention to maintain the abovementioned DR programs admitted to trading on the London Stock Exchange or other recognized stock exchanges.
  • The notices have been made as a part of resignation from all the remaining DR programs in Russia administrated by The Bank of New York Mellon.
  • Forward-looking statements include statements relating to future capital expenditure, business and management strategies and the expansion and growth of Polyus' and/or Polyus group's operations.
  • Polyus and/or any Polyus group company assumes no obligation in respect of, and does not intend to update, these forward-looking statements, except as required pursuant to applicable law.

MD Medical Group Investments Plc: Results of the Extraordinary General Meeting of shareholders

Retrieved on: 
Thursday, February 2, 2023
Mass meeting, Łapino, Financial Conduct Authority, MOEX, EGM, Minutes, National Storage, Remuneration, Russia, LSE, Audit

MD Medical Group Investments Plc: Results of the Extraordinary General Meeting of shareholders

Key Points: 
  • MD Medical Group Investments Plc: Results of the Extraordinary General Meeting of shareholders
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • 23 January 2023 – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG”, “Group” or the “Company”; LSE and MOEX: MDMG), a leading Russian private healthcare provider, today announces that the Company held its Extraordinary General Meeting of shareholders (“EGM”).
  • The Minutes of the EGM are available for viewing at the registered office of the Company at office 9-2, bld.

O`KEY GROUP REPORTS 8.1% NET RETAIL REVENUE GROWTH, DA! DISCOUNTERS REVENUE UP 53.2% IN 2022

Retrieved on: 
Thursday, February 2, 2023
COVID, MOEX, VAT, Yoy, RUB, DA, Growth, LFL, NET, LSE, MAR, KEY, Marketing, Textile, Bicycle

O`KEY GROUP REPORTS 8.1% NET RETAIL REVENUE GROWTH,

Key Points: 
  • O`KEY GROUP REPORTS 8.1% NET RETAIL REVENUE GROWTH,
    O`KEY Group S.A. (LSE, MOEX: OKEY, the “Group” or the “Company”), one of Russia’s leading food retailers, has announced its unaudited operating results for the fourth quarter (Q4) and the twelve months (12M) of 2022.
  • discounters’ net retail revenue surged by 53.2% YoY to RUB 53.3 bn, boosted by a 26.8% increase in LFL revenue and a 26.7% expansion in selling space.
  • [1] Here and throughout this report, net retail revenue, LFL net retail revenue, and online revenue metrics are provided net of VAT.
  • discounters' net retail revenue increased by 37.0% YoY to RUB 14.4 bn, supported by a 14.5% LFL net retail revenue growth and the chain’s expansion.

MD Medical Group Investments Plc: MD Medical Group opens new Medical centre in Moscow Region

Retrieved on: 
Sunday, January 22, 2023
Raffles Medical Group, Infertility, Medicine, Endocrinology, Pregnancy, Patient, MOEX, Hospital, LSE, MAR, Diagnosis, Woman, Medical imaging

MD Medical Group Investments Plc: MD Medical Group opens new Medical centre in Moscow Region

Key Points: 
  • MD Medical Group Investments Plc: MD Medical Group opens new Medical centre in Moscow Region
    Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
  • 13 January 2023 – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG”, “Group” or the “Company”; LSE and MOEX: MDMG), a leading Russian private healthcare provider, today announces the opening of a new out-patient medical centre “Mother&Child Mytishchi” in Moscow Region.
  • The out-patient medical centre "Mother&Child Mytishchi" with a focus on preparation for pregnancy and childbirth is already the third such kind of centre for the Group in Moscow and Moscow Region.
  • The new clinic "Mother&Child Mytishchi" was created in line with MD Medical Group’s customary high standards of medical care and is fitted with world-class equipment.

Lenta IPJSC: Lenta Announces the Holding of the Board of Directors Meeting

Retrieved on: 
Sunday, January 22, 2023
Committee, LSE, MOEX, Audit committee, Audit

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • St. Petersburg, Russia, 22 December 2022: Lenta IPJSC (LSE: LNTA, MOEX: LENT), one of the largest multi-format retail chains in Russia, today announces the holding of the Board of Directors meeting on 21 December 2022.
  • The agenda of the meeting:
    Reports of the Chairpersons of the Company’s Board Committees:
    a.
  • Report of the Chairwoman of the RemunerationCommittee;
    c. Report of the Chairwoman of the Nominations Committee.

MD Medical Group Investments Plc: MD Medical Group announcement of the Extraordinary General Meeting

Retrieved on: 
Sunday, January 22, 2023
The Harley Medical Group, Russia, MOEX, Łapino, Investment, LSE, MAR, Remuneration, Health insurance, Odintsovsky

MD Medical Group Investments Plc: MD Medical Group announcement of the Extraordinary General Meeting

Key Points: 
  • MD Medical Group Investments Plc: MD Medical Group announcement of the Extraordinary General Meeting
    Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • 30 December 2022 – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG”, “Group” or the “Company”; LSE and MOEX: MDMG), a leading Russian private healthcare provider, announces that at a meeting on December 30, 2022 the Board of Directors of MD Medical Group Investments Plc called an Extraordinary General Meeting of shareholders to be held on 23 January 2023 at Lapino hospital, Lapino 111, Odintsovskiy district, Moscow Region, Russian Federation at 10.00 am Moscow time, to consider and, if thought fit, pass 1 resolution which will be proposed as special:
    To appoint GAC Auditors Ltd as the auditor of the separate financial statements of the Company for the year ended 31 December 2022 until the next annual general meeting of the Company and to authorize the Board of Directors to determine the remuneration of auditors.
  • The record date to participate the Extraordinary General Meeting of shareholders shall be 30 December 2022.

TCS Group Holding PLC: notification of Board change under LR9.6

Retrieved on: 
Sunday, January 22, 2023
LI, MOEX, Audit committee, TCS, Tinkoff, Disclosure

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • TCS Group Holding PLC (LI: TCS, MOEX: TCSG) ("Tinkoff" or the "Company"), Russia's leading provider of online financial and lifestyle services via its Tinkoff ecosystem, today announces that Mr Sergey Arsenyev, a non-executive director of the Company, has been appointed a member of the Audit Committee of the Board.
  • There are no other matters requiring disclosure under Listing Rule 9.6.13.

TCS GROUP HOLDING PLC: Headhunter Group plc Appoints Mr Sergey Arsenyev as Non-Executive Director

Retrieved on: 
Sunday, January 22, 2023
LI, MOEX, Audit committee, TCS, Tinkoff, Disclosure

Dissemination of a Regulatory Announcement, transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • TCS Group Holding PLC (LI: TCS, MOEX: TCSG) ("Tinkoff" or the "Company"), Russia's leading provider of online financial and lifestyle services via its Tinkoff ecosystem, today announces that Mr Sergey Arsenyev, a non-executive director of the Company, has been appointed a member of the Audit Committee of the Board.
  • There are no other matters requiring disclosure under Listing Rule 9.6.13.

Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries

Retrieved on: 
Tuesday, December 20, 2022
COVID-19, Psoriasis, Commonwealth, Bone loss, Suppository, Disease, Medication, Bone, MOEX, Infection, Adalimumab, NMPA, Uveitis, Woman, EMA, EEU, Patient, Hypercalcaemia, Multiple myeloma, Partnership, Rheumatoid arthritis, Marketing, Risk, FDA, Eurasian Economic Union, MA, LSE, Menopause, Twelfth, Capsule, GMP, Joint Medical Service (Germany), Prostate cancer, Breast cancer, Osteosarcoma, Gel, Fracture, National Medical Products Administration, Tablet, Osteoporosis, Malignancy, SSA, National Key Universities of Vietnam, Economic union, Crohn's disease, CIS, HCM, Ankylosing spondylitis, EU, Pharmaceutical industry, Generic drug, Medical imaging, Dentistry, Dietary supplement, Fine chemical, Denosumab

Mabwell's 9MW0321 and 9MW0311 have been filed for MA approval with the China National Medical Products Administration (NMPA) at the end of 2021.

Key Points: 
  • Mabwell's 9MW0321 and 9MW0311 have been filed for MA approval with the China National Medical Products Administration (NMPA) at the end of 2021.
  • This strategic partnership will leverage Binnopharm Group's strength as one of the biggest Russian pharmaceutical producers with significant manufacturing, registration, sales and marketing capabilities in Russia and Eurasian Economic Union countries.
  • This strategic partnership is the first to expand Mabwell's presence in Russia and Eurasian Economic Union countries, an important market for biosimilars and innovative drugs."
  • This cooperation also represents an important milestone for Binnopharm Group, and for our patients in Russia and Eurasian Economic Union countries that will ensure the social benefit from an increased access to high-quality affordable medicines."

PhosAgro PJSC: PhosAgro Announces Results of Extraordinary General Meeting of Shareholders

Retrieved on: 
Sunday, December 18, 2022
LSE, London Stock Exchange, CIS, MOEX, Soil, Moscow Exchange, London, Virginia High School League, PhosAgro, MAR, Environment, EGM, Fertilizer, RUB, Security (finance), Renewable energy

Moscow – PhosAgro (Moscow Exchange, LSE: PHOR), one of the world’s leading vertically integrated phosphate-based fertilizer producers, announces the results of an Extraordinary General Meeting of Shareholders (EGM) held on 8 December 2022.

Key Points: 
  • Moscow – PhosAgro (Moscow Exchange, LSE: PHOR), one of the world’s leading vertically integrated phosphate-based fertilizer producers, announces the results of an Extraordinary General Meeting of Shareholders (EGM) held on 8 December 2022.
  • The EGM noted PhosAgro’s strong performance over the first three quarters of 2022.
  • At the EGM, PhosAgro’s shareholders approved a decision to pay out dividends in the amount of RUB 318 per ordinary share.
  • More information about PhosAgro PJSC can be found on our site: www.phosagro.ru